Direct Oral Anticoagulants

The Coagulative cascade. - Clinical Indications for Direct Acting Oral Anticoagulants. - Pharmacokinetic and pharmaco-dynamic of DOACDrug-drug interaction with DO-ACsDirect Oral Anticoagulant Reversal for Management of Bleeding and Emergent Surgery. - Risk stratification for and use of DOAC therapies for stroke prevention in patient with atrial fibrillationUse of DOAC in patients with kidney disease. - Anticoagulation In Elderly Patients With Atrial FibrallationThe Obesity Paradox And The Use Of NOAC. - Direct Oral Anticoagulation In Cancer Patients. - DOACs and Dementia in Patients with Atrial Fibrillation. - Non-Vitamin K Antagonists and Cardiac Implantable Electronic Devices. - Direct Oral Anticoagulants and Atrial Fibrillation Ablation. - DOAC therapy in patients post left atrial appendage occlusion or isolation. - Use of Direct Oral Anticoagulants after Transcatheter Aortic Valve Replacement. - Use of Direct Oral Anticoagulants after Percutaneous Coronary Intervention. - Direct oral anticoagulants and Left Ventricular Thrombosis: the evidence for a good therapeutic approach.